NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.

Moncyte Health's test evaluates biological differences in how cholesterol is transported and processed in cells, which can ...

6A) and 2-DOG uptake assays (Fig. 6B), we showed there to be no significant increase in glucose uptake in response to insulin, although basal uptake remained unchanged. This suggests that only ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

Stronger diesel and heavy-duty vehicle regulations were also added to help the Air Pollution Control Division crack down on ...

Researchers from The University of Manchester have explored the barriers that block patients from attending their cervical ...

To test whether soccer specific training was effective interval training, players ran in a specially designed dribbling track, as well as participating in small group play (five a side). Laboratory ...

Thyroid disease is often missed in older adults because its symptoms overlap with those of “normal aging.” In this ...

For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...

Q1 2025 Earnings Call Transcript February 3, 2025 Operator: Good day. Thank you for standing by. Welcome to Twist ...

Genomic testing in UK dairy herds reaches an all-time high in 2024, with 112,507 females assessed—marking a 19 rise from the previous year.